Polymyalgia Rheumatica (cont.)

Medical Author:
Medical Editor:

What is the treatment for giant cell arteritis?

The goal of the treatment of giant cell arteritis is to suppress the inflammation within the arteries. When giant cell arteritis is diagnosed, high doses of cortisone medications, either intravenously or by mouth are necessary. The high doses required to quiet the inflamed arteries frequently are associated with side effects, including sweats, weight gain, bruising, puffiness of the face, erratic emotions, insomnia, and others.

Also, in order to maintain optimal blood flow, low-dose aspirin is often given to optimize circulation of blood and prevent unwarranted blood clotting within diseased arteries. Studies have shown that low-dose aspirin can reduce the risk of stroke and visual loss in patients with giant cell arteritis.

As in the treatment of polymyalgia rheumatica, because the cortisone medications are associated with potential bone toxicity, causing osteoporosis, patients should consider calcium and vitamin D supplementation. Appropriate patients should have bone mineral density testing, and osteoporosis medications, such as estrogen, alendronate (Fosamax), and risedronate (Actonel), are considered.

What is the prognosis for patients with giant cell arteritis?

Giant cell arteritis usually runs a self-limited course, over months to years. Rarely, the inflammation may not respond to high doses of cortisone, and stronger medications that suppress the immune system have been tried, such as methotrexate (Rheumatrex, Trexall). In most patients, the cortisone medications can gradually be tapered according to the symptoms while the ESR blood test is monitored.

The effects of the arteritis depend not only on the amount of inflammation in the arteries but also on the location of the arteries in various body tissues. Research scientists studying arteritis have discovered that the location of the inflamed arteries in the body and whether it is associated with polymyalgia rheumatica seem to relate to different features of specialized white blood cells (T cells) that are infiltrating the artery walls. If these T cell differences can be further classified according to the patterns of inflammation in patients, this could lead to a new era of "customized" treatments for giant cell arteritis.

Medically Reviewed by a Doctor on 12/8/2014

Patient Comments

Viewers share their comments

Polymyalgia Rheumatica - Symptoms Question: The symptoms of polymyalgia rheumatica can vary greatly from patient to patient. What were your symptoms at the onset of your disease?
Polymyalgia Rheumatica - Diagnosis Question: How was your polymyalgia rheumatica diagnosed?
Polymyalgia Rheumatica - Treatment Question: What was the treatment for polymyalgia rheumatica in you or someone you know?